docetaxel anhydrous has been researched along with Colonic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiMaio, MA; Erdrich, J; Kastenberg, ZJ; Longacre, TA; Rhoads, KF | 1 |
| Colucci, G; Dejaco, H; Grones, A; Marsoner, H; Thaler, W | 1 |
1 review(s) available for docetaxel anhydrous and Colonic Diseases
| Article | Year |
|---|---|
Colonic rupture in a patient on combination chemotherapy for metastasized carcinoma of the esophagogastric junction. Case report and review of the literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cecal Diseases; Cisplatin; Colonic Diseases; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Intestinal Perforation; Middle Aged; Rupture; Stomach Neoplasms; Taxoids; Treatment Outcome | 2005 |
1 other study(ies) available for docetaxel anhydrous and Colonic Diseases
| Article | Year |
|---|---|
Collateral damage: taxane-induced colonic perforation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Colectomy; Colonic Diseases; Colostomy; Docetaxel; Enterocolitis; Female; Humans; Intestinal Perforation; Neoadjuvant Therapy; Predictive Value of Tests; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2015 |